Area 5

Hematological oncology

Articles during the year 2015

Published originals: 40

Impact factor: mean: 8.89, total: 355.42

  • Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking

    Martin-Antonio B, Najjar A, Robinson SN, Chew C, Li S, Yvon E, Thomas MW, Mc Niece I, Orlowski R, Muñoz-Pinedo C, Bueno C, Menendez P, Fernández de Larrea C, Urbano-Ispizua A, Shpall EJ, Shah N
    Cell Death Differ. 2015; 22(1): 96-107. IF: 8.184

  • Life expectancy of young adults with follicular lymphoma

    Conconi A, Lobetti-Bodoni C, Montoto S, Lopez-Guillermo A, Coutinho R, Matthews J, Franceschetti S, Bertoni F, Moccia A, Rancoita PM, Gribben J, Cavalli F, Gaidano G, Lister TA, Montserrat E, Ghielmini M, Zucca E
    Ann Oncol. 2015; (11): 2317-2322. IF: 7.400

  • A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma

    Navarro A, Díaz T, Tovar N, Pedrosa F, Tejero R, Cibeira MT, Magnano L, Rosiñol L, Monzó M, Bladé J, Fernández de Larrea C
    Oncotarget. 2015; 6(3): 1874-1883. IF: 6.359

  • The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

    Díaz-Beyá M, Brunet S, Nomdedéu J, Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I, Ribera JM, Duarte R, de Llano MP, Bargay J, Sampol A, Nomdedeu M, Risueño RM, Hoyos M, Sierra J, Monzo M, Navarro A, Esteve J; Cooperative AML group CETLAM
    Oncotarget. 2015; 6(31): 31613-31627. IF: 6.359

  • Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype

    Ribera-Cortada I, Martinez D, Amador V, Royo C, Navarro A, Beà S, Gine E, de Leval L, Serrano S, Wotherspoon A, Colomer D, Martinez A, Campo E
    Mod Pathol. 2015; 28(11): 1435-1447. IF: 6.187


Published editorials: 3

Impact factor: mean: 8.62, total: 25.85

  • Extramedullary disease in multiple myeloma in the era of novel agents

    Bladé J, Fernández de Larrea C, Rosiñol L
    Br J Haematol. 2015; 169(6): 763-765. IF: 4.971

  • Upfront CyBorD in AL amyloidosis

    Cibeira MT, Bladé J
    Blood. 2015; 126(5): 564-566. IF: 10.452

More articles